Kindstar Global (Beijing) Technology
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of specialty clinical testing services in China, catering primarily to hospitals, including tertiary care facilities. The company specializes in esoteric diagnostic and laboratory testing, alongside offering medical research and clinical trial services to healthcare professionals and pharmaceutical companies. Kindstar Global is committed to enhancing personalized medicine through the development of advanced testing technologies and methodologies. With laboratory facilities located in major cities such as Beijing, Shanghai, and Wuhan, the company aims to meet the needs of patients and healthcare providers by adhering to international standards and guidelines. Established in 2003, Kindstar Global was previously known as Wuhan Kindstar Diagnostics Co., Ltd. and has formed strategic partnerships to further its mission in the clinical testing field.
Haixi Biotechnology is a research and development company of medical testing reagents, aiming to provide accurate testing reagents for medical special inspections, and provide complete scientific research reagents and services for biomedical researchers. Haixi is committed to the R&D, production, sales and service of medical diagnostics and biomedical research reagent products.
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.
TaiLai Biosciences is a biotechnology company based in Shanghai, China, focused on advancing cancer research through its proprietary multiomics technology. The company specializes in developing non-invasive cancer screening and analysis methods, which facilitate a deeper understanding of cancer development and aid in the creation of immune-guided therapies. TaiLai Biosciences offers a range of biopsy products and services that leverage extensive biological data, including DNA, RNA, proteins, and metabolic small molecules. By utilizing bioinformatics and computational science, the company aims to uncover correlations within this complex biological information, ultimately enhancing the effectiveness of cancer diagnosis and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.